Compare SUPN & AERO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SUPN | AERO |
|---|---|---|
| Founded | 2005 | 1934 |
| Country | United States | Mexico |
| Employees | N/A | 17068 |
| Industry | Biotechnology: Pharmaceutical Preparations | Air Freight/Delivery Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.3B |
| IPO Year | 2010 | N/A |
| Metric | SUPN | AERO |
|---|---|---|
| Price | $48.15 | $15.61 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 7 |
| Target Price | ★ $61.60 | $28.57 |
| AVG Volume (30 Days) | ★ 916.2K | 287.8K |
| Earning Date | 05-05-2026 | 04-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $392,755,000.00 | N/A |
| Revenue This Year | $22.70 | $11.85 |
| Revenue Next Year | $19.14 | $4.57 |
| P/E Ratio | ★ N/A | $7.95 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $32.21 | $12.26 |
| 52 Week High | $59.68 | $23.05 |
| Indicator | SUPN | AERO |
|---|---|---|
| Relative Strength Index (RSI) | 54.04 | 37.80 |
| Support Level | $47.48 | $14.28 |
| Resistance Level | $52.24 | $17.17 |
| Average True Range (ATR) | 1.58 | 0.77 |
| MACD | 0.10 | -0.26 |
| Stochastic Oscillator | 38.42 | 18.67 |
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.
Grupo Aeromexico SAB de CV engages in providing air transport services for passengers, goods, and cargo, as well as loyalty program services, training and management services, franchise systems commercialization, and the management of investment in shares. Its services include passenger and cargo transportation, the Club Premier loyalty program, training, charter services, and other aviation-related activities. The company operates through a single operating segment, air transportation, and its geographical presence includes both domestic and international markets, with the majority of revenue coming from the international market.